Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement

NCT05932615 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT05932615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 15, 2024
Completion date
April 30, 2036
Enrollment
1,500 (estimated)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve stenosis, heart disease structural disorder, heart valve diseases